Suicide gene therapy targets prostate cancer cells

14 December 2015

Combining radiation treatment with so-called suicide gene therapy can help to tackle prostate cancer, a new study has found.

Scientists at Houston Methodist Hospital used the method to modify prostate cancer cells so they self-destruct - hence the name.

Survival rates in tests on two groups of patients are substantially higher than those in previous studies. As a result, researchers are confident they have devised a viable new treatment strategy.

Lead author Dr Bin Teh commented: "This is extremely pleasing to us, considering we had patients enrolled in our protocol after other physicians deemed them incurable."

Dr Brian Butler, chair of the Department of Radiation Oncology at Houston Methodist, added that they have created a vaccine using the patient's own cancer cells and devised a treatment that complements what is achievable with traditional radiation and hormonal therapies.

Posted by Jeanette Royston


Health News is provided by Axonn Media in collaboration with Spire Healthcare. Please note that all copy above is ©Axonn Media and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)